Trailing-twelve-month (TTM) revenue is $828.13 Million with a year-over-year growth of +9.48%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2026Period ended 2025-10-31 | $201,033,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-02 |
| Q4 FY2026Period ended 2026-01-31 | $205,570,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-13 |
| Q1 FY2027Period ended 2026-04-30 | $205,095,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-28 |
| Q2 FY2027Period ended 2026-07-31 | $216,429,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-03 |
| TTM revenue | $828,127,000 |
Current P/S: $2,143,367,181 market capitalization ÷ $828,127,000 TTM revenue = 2.59x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:03.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2027 (2026-07-31): $216.43M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:15:29.277Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $95M | $159M | $217M | $254M | $288M | $322M |
| UNITED STATES | $132M | $219M | $330M | $398M |
$828.13M
$828.13 Million
+9.48%
vs. $756.42M a year ago (TTM)
+23.06%
5 Year compound annual growth rate
1 Year
+9.48%
3 Year
+10.94%
5 Year
+23.06%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $790.81M | +$66.93M | +9.25% |
| 2025 | $723.88M | +$71.37M | +10.94% |
| 2024 | $652.50M | +$105.29M | +19.24% |
| 2023 | $547.21M | +$168.78M | +44.60% |
| 2022 | $378.44M | +$151.43M | +66.71% |
| 2021 |
TTM Growth
+9.48%
3-Year CAGR
+10.94%
5-Year CAGR
+23.06%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-26T00:15:29.277Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
| $468M |
| $227.00M |
| +$84.40M |
| +59.18% |
| 2020 | $142.61M | +$65.84M | +85.76% |
